CX3CR1 deficiency promotes muscle repair and regeneration by enhancing macrophage ApoE production

Nature Communications

Volumn 6, Issue , 2015, Pages

  Arnold, Ludovic ^a   Perrin, Hélène ^a   De Chanville, Camille Baudesson ^a   Saclier, Marielle ^b,c,d   Hermand, Patricia ^a   Poupel, Lucie ^a   Guyon, Elodie ^a   Licata, Fabrice ^a   Carpentier, Wassila ^a   Vilar, José ^e   Mounier, Rémi ^b,c,d   Chazaud, Bénédicte ^b,c,d   Benhabiles, Nora ^f   Boissonnas, Alexandre ^a   Combadiere, Béhazine ^a   Combadiere, Christophe ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b INSTITUT COCHIN   (France)

^c CNRS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^f CEA SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CX3CR1; MONOCYTE CHEMOTACTIC PROTEIN 1; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, MOUSE; NOTEXIN; SNAKE VENOM;

CELLS AND CELL COMPONENTS; CYTOGENETICS; GENE EXPRESSION; GENETIC ANALYSIS; MUSCLE; PROTEOMICS; RODENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHEMOKINE RECEPTOR CX3CR1 DEFICIENCY; FEMALE; IN VITRO STUDY; MACROPHAGE FUNCTION; MONOCYTE; MONONUCLEAR PHAGOCYTE; MOUSE; MUSCLE INJURY; MUSCLE REGENERATION; NONHUMAN; PHAGOCYTOSIS; PROTEIN DEFICIENCY; TRANSCRIPTOMICS; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MUSCLE DISEASE; PHYSIOLOGY; SKELETAL MUSCLE;

MUS;

ANIMALS; APOLIPOPROTEINS E; ELAPID VENOMS; GENE EXPRESSION REGULATION; MACROPHAGES; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DISEASES; RECEPTORS, CHEMOKINE;

EID: 84949293493     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9972     Document Type: Article

References (56)

1. McLennan, I. S. Degenerating and regenerating skeletal muscles contain several subpopulations of macrophages with distinct spatial and temporal distributions. J. Anat. 188, 17-28 (1996)
2. Summan, M. et al. Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R1488-R1495 (2006)
3. Arnold, L. et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204, 1057-1069 (2007)
4. Mounier, R. et al. AMPKalpha1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metab. 18, 251-264 (2013)
5. Shireman, P. K. et al. MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration. J. Leukoc. Biol. 81, 775-785 (2007)
6. Contreras-Shannon, V. et al. Fat accumulation with altered inflammation and regeneration in skeletal muscle of CCR2-/-mice following ischemic injury. Am. J. Physiol. Cell. Physiol. 292, C953-C967 (2007)
7. Cantini, M. & Carraro, U. Macrophage-released factor stimulates selectively myogenic cells in primary muscle culture. J. Neuropathol. Exp. Neurol. 54, 121-128 (1995)
8. Saclier, M., Cuvellier, S., Magnan, M., Mounier, R. & Chazaud, B. Monocyte/ macrophage interactions with myogenic precursor cells during skeletal muscle regeneration. FEBS J. 280, 4118-4130 (2013)
9. Sonnet, C. et al. Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems. J. Cell Sci. 119, 2497-2507 (2006)
10. Cochain, C. et al. Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization. Cardiovasc. Res. 88, 186-195 (2010)
11. Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003)
12. Lu, H., Huang, D., Ransohoff, R. M. & Zhou, L. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J. 25, 3344-3355 (2011)
13. Lu, H. et al. Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury. FASEB J. 25, 358-369 (2011)
14. Martinez, C. O. et al. Regulation of skeletal muscle regeneration by CCR2-activating chemokines is directly related to macrophage recruitment. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R832-R842 (2010)
15. Ochoa, O. et al. Delayed angiogenesis and VEGF production in CCR2-/-mice during impaired skeletal muscle regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R651-R661 (2007)
16. Shireman, P. K., Contreras-Shannon, V., Reyes-Reyna, S. M., Robinson, S. C. & McManus, L. M. MCP-1 parallels inflammatory and regenerative responses in ischemic muscle. J. Surg. Res. 134, 145-157 (2006)
17. Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037-3047 (2007)
18. Combadiere, C. et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117, 1649-1657 (2008)
19. Aoyama, T., Inokuchi, S., Brenner, D. A. & Seki, E. CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice. Hepatology 52, 1390-1400 (2010)
20. Karlmark, K. R. et al. The fractalkine receptor CX(3)CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology 52, 1769-1782 (2010)
21. Liu, Z., Condello, C., Schain, A., Harb, R. & Grutzendler, J. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis. J. Neurosci. 30, 17091-17101 (2010)
22. Mizutani, N. et al. Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. J. Immunol. 179, 7478-7487 (2007)
23. Blomster, L. V. et al. CX(3)CR1 deficiency exacerbates neuronal loss and impairs early regenerative responses in the target-ablated olfactory epithelium. Mol. Cell. Neurosci. 48, 236-245 (2011)
24. Clover, A. J., Kumar, A. H. & Caplice, N. M. Deficiency of CX3CR1 delays burn wound healing and is associated with reduced myeloid cell recruitment and decreased sub-dermal angiogenesis. Burns 37, 1386-1393 (2011)
25. Ishida, Y., Gao, J. L. & Murphy, P. M. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J. Immunol. 180, 569-579 (2008)
26. Brigitte, M. et al. Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury. Arthritis Rheum. 62, 268-279 (2010)
27. Hochheiser, K. et al. Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression. J. Clin. Invest. 123, 4242-4254 (2013)
28. Mizutani, M. et al. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J. Immunol. 188, 29-36 (2012)
29. Medina-Contreras, O. et al. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J. Clin. Invest. 121, 4787-4795 (2011)
30. Landsman, L. et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113, 963-972 (2009)
31. Engel, D. R. et al. CX3CR1 reduces kidney fibrosis by inhibiting local proliferation of profibrotic macrophages. J. Immunol. 194, 1628-1638 (2015)
32. Chazaud, B. et al. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J. Cell Biol. 163, 1133-1143 (2003)
33. Griffin, C. A., Apponi, L. H., Long, K. K. & Pavlath, G. K. Chemokine expression and control of muscle cell migration during myogenesis. J. Cell Sci. 123, 3052-3060 (2010)
34. Tacke, F. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185-194 (2007)
35. Sennlaub, F. et al. CCR2() monocytes infiltrate atrophic lesions in agerelated macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice. EMBO Mol. Med. 5, 1775-1793 (2013)
36. Cardona, A. E. et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917-9245 (2006)
37. Freeman M. W. Moore K. J. eLiXiRs for restraining inflammation. Nature Med 9 168-169(2003).
38. Levy, O. et al. Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration. EMBO Mol. Med. 7, 211-226 (2015)
39. Baitsch, D. et al. Apolipoprotein E induces antiinflammatory phenotype in macrophages. Arterioscler. Thromb. Vasc. Biol. 31, 1160-1168 (2011)
40. Van Oosten, M. et al. Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J. Biol. Chem. 276, 8820-8824 (2001)
41. Ali, K., Middleton, M., Pure, E. & Rader, D. J. Apolipoprotein E suppresses the type I inflammatory response in vivo. Circ. Res. 97, 922-927 (2005)
42. Kang, J. et al. Apolipoprotein E-/-mice have delayed skeletal muscle healing after hind limb ischemia-reperfusion. J. Vasc. Surg. 48, 701-708 (2008)
43. Naik, V. et al. Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc. Res. 94, 545-554 (2012)
44. Li, A. C. & Glass, C. K. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 8, 1235-1242 (2002)
45. Grainger, D. J., Reckless, J. & McKilligin, E. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J. Immunol. 173, 6366-6375 (2004)
46. Varga, T. et al. Tissue LyC6-macrophages are generated in the absence of circulating LyC6-monocytes and Nur77 in a model of muscle regeneration. J. Immunol. 191, 5695-5701 (2013)
47. Saederup, N., Chan, L., Lira, S. A. & Charo, I. F. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis. Circulation 117, 1642-1648 (2008)
48. Fumagalli, S., Perego, C., Ortolano, F. & De Simoni, M. G. CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia 61, 827-842 (2013)
49. Donnelly, D. J. et al. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/ iNOS macrophages. J. Neurosci. 31, 9910-9922 (2011)
50. Combadiere, C. et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J. Clin. Invest. 117, 2920-2928 (2007)
51. Chen, Y. W., Zhao, P., Borup, R. & Hoffman, E. P. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J. Cell Biol. 151, 1321-1336 (2000)
52. Porter, J. D. et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum. Mol. Genet. 11, 263-272 (2002)
53. Fang, J., Shi, G. P. & Vaghy, P. L. Identification of the increased expression of monocyte chemoattractant protein-1, cathepsin S, UPIX-1, and other genes in dystrophin-deficient mouse muscles by suppression subtractive hybridization. J. Cell. Biochem. 79, 164-172 (2000)
54. Porter, J. D. et al. Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle. Neuromuscul. Disord. 13, 223-235 (2003)
55. Combadiere, C. et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107, 1009-1016 (2003)
56. Eisen, M. B., Spellman, P. T., Brown, P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 14863-14868 (1998)